Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5051–5100 of 18639
In connection with Mr. Ohri’s termination, on June 3, 2024, the Company has appointed Alan L. Urban as the Company’s Chief Financial Officer.
On June 3, 2024, Manu Ohri’s employment as Chief Financial Officer at GT Biopharma, Inc. (the “Company”) was terminated.
On the Closing Date, Mr. Thomas DeNunzio was appointed as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer, and Director.
On the Closing Date, June 5, 2024, Mr. James Xilas resigned as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, and Treasurer.
the Board of Directors of the Company (the “Board”) appointed David F. Melbourne as Chief Executive Officer of the Company, effective June 7, 2024
Sylvia A. Wulf, who provided notice of her retirement from her role as Chief Executive Officer on June 6, 2024, effective June 7, 2024
On June 6, 2024, C.H. Robinson Worldwide, Inc. (the “Company”) announced that its Board of Directors (the “Board”) appointed Damon Lee as Chief Financial Officer (“CFO”), effective the day after the Company files its Quarterly Report on Form 10-Q for the quarter ending June 30, 2024.
Coherent Corp. (the “Company”) made awards of restricted stock units (“RSU”) and performance stock units (“PSUs”) to its new Chief Executive Officer, James R. Anderson, effective on his start date, June 3, 2024.
Khairul Azmi Bin Ismaon Chairman, Chief Executive Officer and Director
Dr. Ulf Henning Richter Chief Financial Officer
On May 31, 2024, Justin H. Edenfield resigned as Principal Financial and Accounting Officer; Secretary of HG Holdings, Inc. (the “Company”).
In connection with Mr. Edenfield’s resignation, the board of directors of the Company (the “Board”) has elected Anna Lieb to serve as Principal Financial and Accounting Officer; Secretary of the Company effective as of May 31, 2024.
On June 2, 2024, Matthew L. Hoffman resigned as the Chief Financial Officer, Chief Operating Officer and from any and all other positions held by him at The Coretec Group Inc. (the “Company”), effective immediately.
Effective as of June 4, 2024, the Board of Directors (the “Board”) of LuxUrban Hotels Inc. (the “Company”) appointed Michael James as Chief Financial Officer of the Company.
Birger K. Steen, the Company’s Chief Executive Officer (“CEO”), would be leaving the Company effective as of June 6, 2024, and that he will not stand for re-election as a member of the Company’s Board of Directors
Additionally, in connection with Mr. Jensen’s appointment as the Company’s CEO, effective June 6, 2024, Mr. Jensen resigned from his current position as Executive Chair of the Board, and the Board has appointed Daniel Barcelo as Chair of the Board, effective on the same day.
Douglas M. Worman, Executive Vice President and Global Head of Underwriting of the Registrant, was appointed President and Chief Executive Officer of the Registrant, effective January 1, 2025.
Anat Ashkenazi resigned as Executive Vice President and Chief Financial Officer of the Company to pursue another career opportunity outside of the pharmaceutical industry.
Scott Carter, a member of the Board of Directors of the Company (the “Board”), was appointed as Interim Chief Executive Officer of the Company, effective as of June 1, 2024.
Sterling Check Corp. (the “Company”) has appointed Richard Dziadzio as Executive Vice President, Interim Chief Financial Officer, effective June 5, 2024.
On May 31, 2024, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Shane Hostetter as Chief Financial Officer, effective as of July 1, 2024.
appointed John Bostjancic, age 53, to serve as Chief Financial Officer of the Company, effective June 5, 2024.
As previously disclosed, on April 25, 2024, the board of directors (the “Board”) of Akari Therapeutics, Plc (the “Company”) appointed Samir R. Patel, M.D., a member of the Board, as Interim President and Chief Executive Officer, effective May 1, 2024, to serve in such capacities until such time as determined by the Board.
On May 30, 2024, Mark J. Suchinski tendered his resignation as Senior Vice President and Chief Financial Officer of Spirit AeroSystems Holdings, Inc. (the “Company”) and Spirit AeroSystems, Inc. (“Spirit”), in order to pursue another professional opportunity.
On June 4, 2024, the Board of Directors (the “Board”) of the Company appointed Irene M. Esteves as Executive Vice President and Chief Financial Officer of the Company and of Spirit.
Khairul Azmi Bin Ismaon was appointed Chief Executive Officer.
Dr. Ulf Henning Richter was appointed Chief Financial Officer.
The promotion of Robert Helm to Executive Vice President and Chief Financial Officer from Senior Vice President and Chief Financial Officer, effective as of June 5, 2024
On June 5, 2024, Alphabet Inc. (“Alphabet”) announced the appointment of Anat Ashkenazi, age 51, as the new Chief Financial Officer and Senior Vice President of Alphabet and Google LLC, effective July 31, 2024.
On June 1, 2024, the Board of Directors (the “ Board ”) of Sprinklr, Inc. (the “ Company ”) appointed Trac Pham, the Company’s Interim Chief Operating Officer, as the Company’s Co-Chief Executive Officer and co-principal executive officer, effective June 5, 2024.
In connection with Mr. Thomas’s appointment as Co-Chief Executive Officer, Mr. Thomas will receive an annual base salary of $500,000 and an annual discretionary bonus with a target amount equal to 100% of his annual base salary.
the Company promoted Rob Coldrake to serve as the Chief Financial Officer with immediate effect following the departure of Paul Edgecliffe-Johnson.
the Board concluded that it was in the Company’s best interests for Mr. Edgecliffe-Johnson to step down from his role as Chief Financial Officer of the Company, effective as of May 31, 2024.
appointed Jeffrey R. Geygan to the position of Interim Chief Executive Officer, effective May 16, 2024
Michael L. Berger, then serving as President, as Chief Executive Officer and a member of the Board;
On June 4, 2024, agilon health, inc. (the “Company”) appointed Jeff Schwaneke to serve as the Company’s Chief Financial Officer and Executive Vice President effective July 1, 2024 (the “Effective Date”).
As previously disclosed, effective April 8, 2024, Carlos Rodriguez departed from his role as Chief Financial Officer of HF Foods Group Inc. (the “Company”).
Aaron Berg, who has been serving as the Company’s Executive Vice President, President U.S., has replaced Mr. Holt as President and Chief Executive Officer, effective June 4, 2024 (the “CEO Start Date”).
On June 3, 2024, Patrick Holt notified Amarin Corporation plc (the “Company”) of his decision to voluntarily resign as President and Chief Executive Officer of the Company, effective immediately.
Also on June 3, 2024, the Board appointed Paul Weibel, the Company’s Chief Financial Officer, as the Company’s Chief Executive Officer and principal executive officer, effective as of the Effective Date.
The Board also appointed Joshua Malm, the Company’s Interim Chief Accounting Officer, as the Company’s Interim Chief Financial Officer and principal financial officer and principal accounting officer, effective as of the Effective Date.
On June 3, 2024, Susan Brennan notified 5E Advanced Materials, Inc. (the “Company”) of her resignation as President and Chief Executive Officer of the Company and as a director of the Board of Directors of the Company (the “Board”), effective as of June 3, 2024
On May 21, 2024 William O’Neill, then Chief Executive Officer and a Director of the Company, informed other members of the Company’s Board of Directors (by email) of his intention to resign from his positions with the Company.
Also on May 31, 2024, Robert A. Seiser was appointed as Sr. Vice President and Chief Financial Officer, effective August 1, 2024.
Although Mr. Clemens will remain an employee of the Company as Vice President until the end of September to ensure a smooth transition, he is stepping down as Chief Financial Officer, effective July 31, 2024.
Karin L. Bell, the Company’s Chief Financial Officer, notified the Company of her planned retirement effective upon the date which the Company files its Annual Report on Form 10-K for the year ended December 31, 2024 (the “10-K Filing Date”) and her resignation as Chief Financial Officer and principal financial officer of the Company, effective as of the Effective Date,
On May 31, 2024, Edmund Reese, Vice President and Chief Financial Officer of Broadridge Financial Solutions, Inc. (“Broadridge” or the “Company”), informed the Company that he is resigning to pursue other career opportunities, effective June 30, 2024.
Ashima Ghei will serve as Interim Chief Financial Officer of Broadridge, effective July 1, 2024, as the Company conducts a search for a new chief financial officer.
On June 4, 2024, Aon plc (the “Company”) announced that Edmund Reese will join the Company as Executive Vice President, Finance, effective July 1, 2024 (the “Effective Date”), and will be appointed Chief Financial Officer of the Company, effective July 29, 2024.
John Crowley (Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer) and Mohit Rawat (President and Chief Business Officer) ceased to serve in their capacities as executive officers of Fusion.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.